The results of a previous study suggest that NT-proBNP could be a biomarker for stroke [18], and increased blood levels of NT-proBNP have been reported in patients with symptomatic HF due to left ventricular systolic and diastolic dysfunction [19]. Here, NPPB is linked to stroke disorder.